Suppr超能文献

蛋白磷酸酶1和2A在胶原蛋白-血小板相互作用中的作用。

The role of protein phosphatases 1 and 2A in collagen-platelet interaction.

作者信息

Chiang T M

机构信息

Veterans Affairs Medical Center, Memphis, Tennessee 38104.

出版信息

Arch Biochem Biophys. 1993 Apr;302(1):56-63. doi: 10.1006/abbi.1993.1180.

Abstract

Okadaic acid, a specific inhibitor of phosphoserine/threonine protein phosphatases 1 and 2A, was used to determine whether these protein phosphatases play a role in collagen-induced platelet aggregation and release reaction as measured by ATP release. Collagen-induced platelet aggregation and ATP release were inhibited by the addition of okadaic acid to platelet-rich plasma in a dose-dependent manner. The inhibitory effect of okadaic acid on collagen-induced platelet aggregation correlated with phosphorylation of proteins with M(r) 14.4, 25, 32, 36, 50, 60, and 80 kDa. The 14.4-kDa protein was purified to apparent homogeneity by electroelution from gel slices. This protein reacted with antibodies to phospholipase A2 (PLA2). Since okadaic acid inhibited PLA2 activity in platelet-rich plasma but not in the PLA2 assay mixture, the effect appears to be indirect. Furthermore, using a combination of immunoprecipitation and measurement of enzyme activity, PLA2 activity was inhibited in the presence of okadaic acid. The inhibited activity could not be restored by the addition of collagen. These results suggest that the phosphorylated form of PLA2 is inactive. Using [32P]glycogen phosphorylase a as substrate, protein phosphatase activity was inhibited by okadaic acid in a concentration-dependent manner. An immunoblot of platelet homogenates with anti-protein phosphatase 1 showed a band with M(r) 50 kDa reacting with the antibodies, suggesting that the 50-kDa protein is protein phosphatase 1. These data clearly show that okadaic acid increases the phosphorylation and indirectly decreases the activity of PLA2, but whether inhibition of PLA2 activity is related to collagen-induced platelet aggregation and release reaction remains to be determined.

摘要

冈田酸是磷酸丝氨酸/苏氨酸蛋白磷酸酶1和2A的特异性抑制剂,用于确定这些蛋白磷酸酶是否在胶原诱导的血小板聚集和通过ATP释放测定的释放反应中发挥作用。向富含血小板的血浆中添加冈田酸以剂量依赖的方式抑制了胶原诱导的血小板聚集和ATP释放。冈田酸对胶原诱导的血小板聚集的抑制作用与分子量为14.4、25、32、36、50、60和80 kDa的蛋白质的磷酸化相关。通过从凝胶切片中电洗脱将14.4 kDa的蛋白质纯化至表观均一性。该蛋白质与抗磷脂酶A2(PLA2)抗体发生反应。由于冈田酸抑制富含血小板血浆中的PLA2活性,但不抑制PLA2测定混合物中的活性,因此该作用似乎是间接的。此外,使用免疫沉淀和酶活性测量相结合的方法,在存在冈田酸的情况下PLA2活性受到抑制。添加胶原不能恢复被抑制的活性。这些结果表明PLA2的磷酸化形式是无活性的。以[32P]糖原磷酸化酶a为底物,冈田酸以浓度依赖的方式抑制蛋白磷酸酶活性。用抗蛋白磷酸酶1对血小板匀浆进行免疫印迹显示,有一条分子量为50 kDa的条带与抗体发生反应,表明50 kDa的蛋白质是蛋白磷酸酶1。这些数据清楚地表明,冈田酸增加了磷酸化并间接降低了PLA2的活性,但PLA2活性的抑制是否与胶原诱导的血小板聚集和释放反应有关仍有待确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验